This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
Freelance translator and/or interpreter, Verified member
Data security
This person has a SecurePROโข card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePROโข card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
Translation - English LUNG-OSIME-SRS research is targeted to lung cancer patients of the NSCLC type who have an EGFR mutation and asymptomatic brain metastases, who receive treatment with the TKI Inhibitor called Osimertinib. Osimertinib is an accepted treatment for these patients. This medication crosses the Blood-Brain Barrier, and it is therefore expected that this medicine will bring about the shrinking of the brain metastases. Radiation treatment of the brain in addition to Osimertinib is not an accepted treatment for these patients. The research proposes the addition of stereotactic radiosurgery (SRS) to these patients two months following treatment with Osimertinib alone. The participants in the research will be randomly placed into one of two branches of the research: in the first, they will receive combination treatment with SRS and in the second will continue with the accepted Osimertinib treatment alone. The objectives of the research are to determine whether treatment earlier than the accepted with SRS can extend the period of time without progression of brain metastases (CNS-Progression free survival). The secondary objectives of the research are to determine if early and focused radiation therapy of the SRS type can improve the cognitive abilities of the patient, their quality of life, the period of time until they are required to undergo Whole Brain Radiation and their life expectancy.
Neck: no pathological uptake of FDG noted.
No significant findings in the neck organs. No observed enlargement of lymph nodes.
Chest: No pathological uptake of FDG.
Post-operative changes in the breast and in the right armpit observed.
Small lymph nodes in the right armpit imaged, without pathological uptake of FDG.
Interstitial changes at the base of the lungs. The mediastinum and entrances to the lungs are without enlarged nodes. No evidence of pleural or pericardial discharge.
Abdomen and pelvis: no pathological uptake of FDG seen.
Liver tissue is consistent with multi-focal filtering of lipids.
The kidneys, spleen, pancreas and adrenals are normal.
Retro-peritoneum without enlarged nodes.
The uterus with no pathological uptake of the FDG. No evidence of pelvic tumors.
More
Less
Translation education
PhD - UCL
Experience
Years of experience: 17. Registered at ProZ.com: Jun 2020. Became a member: May 2021.
Adobe Acrobat, memoQ, MemSource Cloud, Microsoft Excel, Microsoft Office Pro, Microsoft Word, Powerpoint, Subtitle Edit, Subtitle Editor, Trados Studio, XTM
I have a extensive experience in academia (research and education) and highly enjoy writing. Given that I also enjoy developing my language skills, the fields of translation, writing and editing are a great fit for me. I find my work rewarding and work hard to provide the best possible service. I translate all kinds of documents, from letters to powerpoint presentations and certificates. While much of my work is science or medical related, I am competent in translating other subject matter too. I enjoy subtitling projects and transcription as well.
Member since May '21
Expertise 
Portfolio